Walter P. Carney
Geen lopende functies
Profiel
Walter P.
Carney served as Director at BioLegend CNS, Inc., Principal at OSI Pharmaceuticals, Inc. and Bayer Healthcare LLC, Vice President-Research & Development at Oncogene Science, Inc., and Assistant Clinical Professor at Tufts University.
He also served as Interim President & Chief Scientific Officer at On-Q-ity, Inc. from 2011 to 2014.
Carney earned a doctorate degree from Thomas Jefferson University in 1978.
Eerdere bekende functies van Walter P. Carney
Bedrijven | Functie | Einde |
---|---|---|
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | President | 05-04-2012 |
Tufts University | Corporate Officer/Principal | - |
BioLegend CNS, Inc.
BioLegend CNS, Inc. BiotechnologyHealth Technology BioLegend CNS, Inc. provides monoclonal antibodies used in the research of cancer, infectious disease and neurodegenerative diseases. The company is headquartered in Boston, MA. | Director/Board Member | - |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Corporate Officer/Principal | - |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Walter P. Carney
Thomas Jefferson University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Oncogene Science, Inc.
Oncogene Science, Inc. Medical/Nursing ServicesHealth Services Oncogene Science, Inc. provided cancer diagnostics services. The company was founded in 1983 and was headquartered in Uniondale, NY. | Health Services |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
BioLegend CNS, Inc.
BioLegend CNS, Inc. BiotechnologyHealth Technology BioLegend CNS, Inc. provides monoclonal antibodies used in the research of cancer, infectious disease and neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |